These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34055495)

  • 41. Abrogation of tumor necrosis factor-alpha converting enzyme inhibits embryonic lung morphogenesis in culture.
    Zhao J; Chen H; Wang YL; Warburton D
    Int J Dev Biol; 2001 Jun; 45(4):623-31. PubMed ID: 11460998
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of individual cysteine residues in the processing, structure, and function of human macrophage colony-stimulating factor.
    Deng P; Wang YL; Pattengale PK; Rettenmier CW
    Biochem Biophys Res Commun; 1996 Nov; 228(2):557-66. PubMed ID: 8920951
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inactivating mutations block the tumor necrosis factor-alpha-converting enzyme in the early secretory pathway.
    Villanueva de la Torre T; Bech-Serra JJ; Ruiz-Paz S; Baselga J; Arribas J
    Biochem Biophys Res Commun; 2004 Feb; 314(4):1028-35. PubMed ID: 14751236
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Disulfide-linked dimers of human adrenaline synthesizing enzyme PNMT are catalytically active.
    Gee CL; Nourse A; Hsin AY; Wu Q; Tyndall JD; Grunewald GL; McLeish MJ; Martin JL
    Biochim Biophys Acta; 2005 Jun; 1750(1):82-92. PubMed ID: 15893506
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Proteolytic maturation of Drosophila Neuroligin 3 by tumor necrosis factor α-converting enzyme in the nervous system.
    Wu J; Tao N; Tian Y; Xing G; Lv H; Han J; Lin C; Xie W
    Biochim Biophys Acta Gen Subj; 2018 Mar; 1862(3):440-450. PubMed ID: 29107812
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ectodomain shedding of TNF-alpha is enhanced by nardilysin via activation of ADAM proteases.
    Hiraoka Y; Yoshida K; Ohno M; Matsuoka T; Kita T; Nishi E
    Biochem Biophys Res Commun; 2008 May; 370(1):154-8. PubMed ID: 18355445
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intracellular maturation and transport of tumor necrosis factor alpha converting enzyme.
    Peiretti F; Canault M; Deprez-Beauclair P; Berthet V; Bonardo B; Juhan-Vague I; Nalbone G
    Exp Cell Res; 2003 May; 285(2):278-85. PubMed ID: 12706122
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mixed phenotype hepatocellular carcinoma after transarterial chemoembolization and liver transplantation.
    Zen C; Zen Y; Mitry RR; Corbeil D; Karbanová J; O'Grady J; Karani J; Kane P; Heaton N; Portmann BC; Quaglia A
    Liver Transpl; 2011 Aug; 17(8):943-54. PubMed ID: 21491582
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Shedding of interleukin-6 receptor and tumor necrosis factor alpha. Contribution of the stalk sequence to the cleavage pattern of transmembrane proteins.
    Althoff K; Reddy P; Voltz N; Rose-John S; Müllberg J
    Eur J Biochem; 2000 May; 267(9):2624-31. PubMed ID: 10785383
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Conversion of the tetrameric restriction endonuclease Bse634I into a dimer: oligomeric structure-stability-function correlations.
    Zaremba M; Sasnauskas G; Urbanke C; Siksnys V
    J Mol Biol; 2005 Apr; 348(2):459-78. PubMed ID: 15811381
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nardilysin enhances ectodomain shedding of heparin-binding epidermal growth factor-like growth factor through activation of tumor necrosis factor-alpha-converting enzyme.
    Nishi E; Hiraoka Y; Yoshida K; Okawa K; Kita T
    J Biol Chem; 2006 Oct; 281(41):31164-72. PubMed ID: 16923819
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Substrate specificity and inducibility of TACE (tumour necrosis factor alpha-converting enzyme) revisited: the Ala-Val preference, and induced intrinsic activity.
    Black RA; Doedens JR; Mahimkar R; Johnson R; Guo L; Wallace A; Virca D; Eisenman J; Slack J; Castner B; Sunnarborg SW; Lee DC; Cowling R; Jin G; Charrier K; Peschon JJ; Paxton R
    Biochem Soc Symp; 2003; (70):39-52. PubMed ID: 14587281
    [TBL] [Abstract][Full Text] [Related]  

  • 53.
    Mal A; Dey P; Hayes RM; McCarthy JV; Ray A; De A
    ACS Omega; 2020 Dec; 5(48):30808-30816. PubMed ID: 33324790
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of growth factor-induced serine phosphorylation of tumor necrosis factor-alpha converting enzyme and of an alternatively translated polypeptide.
    Fan H; Turck CW; Derynck R
    J Biol Chem; 2003 May; 278(20):18617-27. PubMed ID: 12621058
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tumor necrosis factor-alpha-converting enzyme controls surface expression of c-Kit and survival of embryonic stem cell-derived mast cells.
    Cruz AC; Frank BT; Edwards ST; Dazin PF; Peschon JJ; Fang KC
    J Biol Chem; 2004 Feb; 279(7):5612-20. PubMed ID: 14625290
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adamalysins. A family of metzincins including TNF-alpha converting enzyme (TACE).
    Killar L; White J; Black R; Peschon J
    Ann N Y Acad Sci; 1999 Jun; 878():442-52. PubMed ID: 10415747
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The tumor necrosis factor-alpha converting enzyme (TACE): a unique metalloproteinase with highly defined substrate selectivity.
    Mohan MJ; Seaton T; Mitchell J; Howe A; Blackburn K; Burkhart W; Moyer M; Patel I; Waitt GM; Becherer JD; Moss ML; Milla ME
    Biochemistry; 2002 Jul; 41(30):9462-9. PubMed ID: 12135369
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Conformational stability of dimeric and monomeric forms of the C-terminal domain of human immunodeficiency virus-1 capsid protein.
    Mateu MG
    J Mol Biol; 2002 Apr; 318(2):519-31. PubMed ID: 12051856
    [TBL] [Abstract][Full Text] [Related]  

  • 59. TIMP-3 ameliorates hepatic ischemia/reperfusion injury through inhibition of tumor necrosis factor-alpha-converting enzyme activity in rats.
    Tang ZY; Loss G; Carmody I; Cohen AJ
    Transplantation; 2006 Dec; 82(11):1518-23. PubMed ID: 17164725
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Structure-based rational design of peptide hydroxamic acid inhibitors to target tumor necrosis factor-α converting enzyme as potential therapeutics for hepatitis.
    Wu D; Gu Q; Zhao N; Xia F; Li Z
    J Drug Target; 2015 Dec; 23(10):936-42. PubMed ID: 26061299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.